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ABSTRACT In previous work, antibodies prepared
against chemically synthesized peptides predicted from the
DNA sequence were used to identify the polypeptides encoded
in three of the eight unassigned reading frames (URFs) of
human mitochondrial DNA (mtDNA). In the present study, this
approach has been extended to other human mtDNA URFs. In
particular, antibodies directed against the NH2-terminal
octapeptide of the putative URF2 product specifically precip-
itated component 11 of the HeLa cell mitochondrial translation
products, the reaction being inhibited by the specific peptide.
Similarly, antibodies directed against the COOH-terminal
nonapeptide of the putative URF4 product reacted specifically
with components 4 and 5, and antibodies against a COOH-
terminal heptapeptide of the presumptive URF4L product
reacted specifically with component 26. Antibodies against the
NH2-terminal heptapeptide of the putative product of URFS
reacted with component 1, but only to a marginal extent;
however, the results of a trypsin fingerprinting analysis of
component 1 point strongly to this component as being the
authentic product of URFS. The polypeptide assignments to the
mtDNA URFs analyzed here are supported by the relative
electrophoretic mobilities of proteins 11, 4-5, 26, and 1, which
are those expected for the molecular weights predicted from the
DNA sequence for the products of URF2, URF4, URF4L, and
URF5, respectively. With the present assignment, seven of the
eight human mtDNA URFs have been shown to be expressed in
HeLa cells.
Mammalian mitochondrial DNAs (mtDNAs) contain, be-
sides five genes of identifiable function, eight unassigned
reading frames (URFs), which have a high degree of se-
quence homology and strong conservation in size and map-
ping position in different species (1-5). A set of homologous
reading frames was subsequently found in the mtDNAs of
Xenopus laevis (6) and Drosophila species (7-9). Surprising-
ly, these reading frames, with the exception of one (10, 11),
have no obvious amino acid sequence homology to any of the
reading frames of the mtDNAs from yeasts (12, 13). How-
ever, URFs with a partial homology to several of the animal
mtDNA URFs occur in other lower eukaryotic organisms-
i.e., Aspergillus nidulans (14), Neurospora crassa (15-17),
protozoa (18, 19), unicellular algae (20), and plants (14). The
evolutionary persistence of these URFs, as well as the
evidence of their transcription into typical mRNAs in HeLa
cells (21), suggested very early that they code for functional
proteins. Direct evidence that several of these URFs are
indeed expressed was first obtained in HeLa cells by the use
of antibodies directed against synthetic peptides predicted
from the DNA sequence. Thus, the polypeptides
encoded in URFI, URF3, and URFA6L were identified on
gels, and the identification was confirmed, in the case of
URFA6L, by analysis of protease fingerprints (22, 23). An
independent identification of the polypeptide specified by
URF3 was obtained by the analysis of a polymorphism of the
gene and of the encoded protein (24). In the work reported
here, four additional URFs-i.e., URF2, URF4, URF4L, and
URFS-have been shown by the use of anti-peptide antibod-
ies and by fingerprinting analysis to be expressed in HeLa
cells, and the corresponding polypeptides have been identi-
fied among the mitochondrial translation products.
MATERIALS AND METHODS
Peptide Synthesis, Attachment to Carrier Proteins, and
Preparation of Antisera. The techniques used for the synthe-
sis and characterization of the peptides, their attachment to
bovine serum albumin, and the preparation and testing of
antisera have been described (22, 25). Antibodies directed
against the NH2-terminal octapeptide of URF2 (anti-URF2-
N), against the NH2-terminal heptapeptide of URF5 (anti-
URF5-N), against the NH2-terminal decapeptide of cyto-
chrome c oxidase subunit II (anti-COII-N), against the
COOH-terminal nonapeptide of URF4 (anti-URF4-C), and
against the COOH-terminal heptapeptide of URF4L (anti-
URF4L-C) were used.
In Vivo Labeling of HeLa Cell Mitochondrial Translation
Products. HeLa cells were either labeled directly in methio-
nine-free medium for 2 hr with [35S]methionine (1040-1425
Ci/mmol, 10-130 ,uCi/ml; 1 Ci = 37 GBq) in the presence of
emetine (22) at 100 ,ug/ml or were grown for 22 hr in complete
medium in the presence of chloramphenicol (CAP) at 40
,ug/ml, then labeled for 2 hr with [35S]methionine in methio-
nine-free medium in the presence of cycloheximide at 100
,ug/ml, and finally chased for 2 hr in complete medium (26).
The above conditions ofCAP treatment inhibit mitochondrial
protein synthesis in HeLa cells by >90% while allowing
growth of the cells at a normal rate for 2 days (27); therefore,
they could conceivably allow accumulation in the cytosol
and/or mitochondria of cytoplasmic subunits of the enzyme
complexes of the inner mitochondrial membrane, as has been
reported to occur in S. cerevisiae (28) and N. crassa (29), and
thus increase the stability and/or integration of the
mitochondrially synthesized subunits. A marked increase in
the 2-hr pulse-labeling of several mitochondrial translation
Abbreviations: URFs, unassigned reading frames; mtDNA, mito-
chondrial DNA; URFI-URF6, specific URFs in mtDNA; CAP,
chloramphenicol; anti-URF5-N and anti-URF2-N, antibodies
against the NH2-terminal heptapeptide of URF5 and octapeptide of
URF2; anti-COII-N, antibody against the NH2-terminal decapeptide
of cytochrome c oxidase; anti-URF4-C and anti-URF4L-C, antibod-
ies against the COOH-terminal nonapeptide of URF4 and
heptapeptide of URF4L.
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Table 1. Synthetic peptides and modes of attachment
Attachment Degree of BSA
Source Sequence* proceduret substitution*
URF2 (amino terminus) Ile-Asn-Pro-Leu-Ala-Gln-Pro-V1I-(Glu) EDC 21
URF4 (amino terminus) Met-Leu-Lys-Leu-Jle-Val-Pto-(Glu) EDC 15
URF4 (carboxyl terminus) (Lys)-Pro-Asp-Ile-Ile-Thr-Gly-Phe-Ser-Ser GLUT 18
URF4L (amino terminus) Met-Po-Leu-Ile-Tyr-Met-Asn-(Glu) EDC 12
URF4L (carboxyl terminus) (Lys)-His-Asn-Liu-Asn-Leu-Leu-Gln-X§ GLUT 24
URF5 (amino terminus) Met-Thr-Met-His-Thr-Thr-Met-(Aza-Glu) EDC 16
URF5 (carboxyl terminus) (Lys)-Thr-Leu-Leu-Ltu-lle-Thr GLUT 32
*Residues in parentheses were incorporated for attachment purposes. 0, radioactive residue.
tEDC, water-soluble carbodilmide; GLUT, glutaraldehyde.
*Number of peptide molecules per bovine serum albumin (BSA) molecule.
X = a-aminobutyric acid, replacing the encoded COOH-terminal cysteine.
products, including component 11, after CAP-pretreatment
has been recently observed (30).
Immunoprecipitation of Mitochondrial Translation Prod-
ucts and Analysis of Immunoprecipitate. The mitochondrial
fraction was isolated as described (22). The immunoprecip-
itation experiments were carried out by a modification of the
procedure as reported (22). All operations were performed at
room temperature unless otherwise specified. In brief, sam-
ples of mitochondrial suspension (not sonicated) (110-760 ,ug
of protein) were heated at 37°C for 60 min and then at 100°C
for 10 min in the presence of 1% NaDodSO4. The samples
were placed in NET buffer (0.05 M Tris-HCl, pH 8.9
(25°C)/0.15 M NaCl/0.005 M EDTA, final concentrations)
containing 0.1% NaDodSO4, 1 mg ofovalbumin per ml, 0.001
M phenylmethylsulfonyl fluoride, 0.02% NaN3, and 0.002 M
methionine. After a 30-min incubation with 125 or 250 ,ul of
formaldehyde-fixed Staphylococcus aureus Cowan strain I
suspension (Zysorbin, Zymed Laboratories, Burlingame,
CA), the mixtures were centrifuged in an Eppendorf
Microfuge for 2 min. After addition to each supernatant of250
,ug or 500 ,ug of the gamma-globulin fraction from the
particular antiserum freed of anti-bovine serum albumin
antibodies (22) or of the total gamma globulins from normal
serum, the mixtures were incubated overnight at 4°C under
shaking. After 30 min of further incubation at room temper-
ature, a 10-fold protein excess of a 0.1% NaDodSO4 mito-
chondrial lysate from unlabeled cells and 0.25 or 0.50 ml of
Zysorbin were added, and the mixtures were kept for 60 min
under shaking and then centrifuged in the Microfuge for 2
min. The pellets were washed three times with NET buffer
containing 0.1% NaDodSO4, 1 mg ofovalbumin per ml, 0.001
M phenylmethylsulfonyl fluoride, and 0.002 M methionine
and one time with 0.01 M Tris HCl (pH 6.7) and finally were
extracted with 60 ,u of 8 M urea/4% NaDodSO4/0.01 M
Tris HCl, pH 7.4/0.1% ,B-mercaptoethanol for 60 min at 37°C
and usually for 10 additional min at 50°C. A portion of the
extract was run on a NaDodSO4/urea/polyacrylamide gel or
a NaDodSO4 linear-gradient polyacrylamide gel (23) pre-
pared with NaDodSO4 from MCB (technical grade; MCB
Manufacturing Chemists, Cincinnati, OH) or Sigma (L5750,
=70% lauryl sulfate) or Bio-Rad, as specified below.
Fingerprinting Analysis of Tryptic Digests. The procedure
used was as described (22), except that the thin-layer cellu-
lose plate was exposed for autoradiography rather than for
fluorography and then was stained with ninhydrin.
RESULTS
Preparation of Antipeptide Antibodies. Table 1 shows the
sequences of the peptides of the putative products of URF2,
URF4, URF4L, and URFS, which were chosen for synthesis,
their mode of attachment to bovine serum albumin, and the
degree of substitution obtained. The preparation of anti-
COII-N has been described (22).
Immunoprecipitation of Mitochondrial Translation Prod-
ucts by Anti-URF2-N, Anti-URF4-C, and Anti-URF4L-C An-
tibodies. Immunoprecipitation experiments with NaDodSO4
mitochondrial lysate from HeLa cells labeled for 2 hr with[35S]methionine in the presence of emetine at 100 ,ug/ml and
gamma globulins from an anti-URF2-N, anti-URF4-C, or
anti-URF4L-C antiserum showed that each type of antibody
produced a precipitate exhibiting in a NaDodSO4/urea/poly-
acrylamide gel a single specific band. This band correspond-
ed to a mitochondrial translation product and was absent in
the normal serum control. One such experiment is shown in
Fig. MA. A band with the same mobility as that of component
11 of the profile of the HeLa cell mitochondrial translation
products (31) is visible in the pattern of the immunopre-
cipitate obtained with gamma globulins from an anti-URF2-N
antiserum. Similarly, the electrophoretic pattern of the
immunoprecipitate obtained with gamma globulins from an
anti-URF4-C antiserum exhibits a band corresponding in
mobility to components 4 and 5, while the pattern of the
precipitate formed with anti-URF4L-C gamma globulins
shows a band corresponding to component 26. In the pattern
of the immunoprecipitate obtained with anti-URF4-C anti-
bodies, there is, in addition to the specific band, some trailing
heterogeneous material extending up to the origin; this
suggests a tendency of the URF4 product to aggregate.
Antibodies against the NH2-terminal heptapeptide of the
URF4 product or of the URF4L product, though strongly
reactive with the corresponding peptide, did not precipitate
any mitochondrial translation product.
Fig. 2 shows that each specific peptide (added in the
amount of 5 ,g) competed completely with the corresponding
mitochondrial translation product in the precipitation by the
anti-peptide antibodies. In this experiment, the mitochondri-
al lysate had been prepared from cells grown for 22 hr in the
presence of CAP, then labeled for 2 hr with [35S]methionine
in the presence of cycloheximide at 100 ,ug/ml, and finally
chased for 2 hr in drug-free medium. Note the presence in the
electrophoretic pattern ofthe mitochondrial translation prod-
ucts of bands of higher molecular weight than component 1
because of the labeling of cytoplasmically synthesized pro-
teins during the chase.
Components 4 and 5 were not resolved in the marker
pattern of Figs. 1A and 2, in contrast to what had been
observed previously (31). Tests carried out under a variety of
conditions showed that the source ofNaDodSO4 affected the
pattern of the mitochondrial translation products. In the
experiments of Figs. 1A and 2, MCB NaDodSO4 had been
used both for solubilization of the mitochondrial fraction and
for electrophoresis. When Sigma NaDodSO4 instead ofMCB
NaDodSO4 was used, a marker pattern was obtained in which
components 4 and 5 were resolved over a heterogeneous
background (Fig. 1B). Furthermore, both components 4 and
5 and the heterogeneous material appeared to be precipitated
by anti-URF4-C antibodies (Fig. 1B). It should also be noted
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that, when Sigma NaDodSO4 was used, no well-defined band
corresponding to component 11 was visible, in contrast to the
case with MCB NaDodSO4, and that instead a smear was
visible between the two bands corresponding to components
7-10 and 12. Electrophoretic analysis of the immunopre-
cipitate obtained with anti-URF2-N antibodies in Sigma
NaDodSO4 showed that the precipitated component 11 mi-
grates in this NaDodSO4 partly as a distinct band moving
slightly more slowly than the 7-10 band and partly as
faster-moving heterogeneous material extending up to the
component 12 band (Fig. 1C). In some electrophoretic runs
in Sigma NaDodSO4 of the total mitochondrial translation
products, the discrete band corresponding to component 11
was partly resolved from the 7-10 band (not shown).
Fig. 3 shows the patterns obtained when the mitochondrial
translation products precipitated by anti-URF2-N, anti-
URF4-C, or anti-URF4L-C antibodies were analyzed in a
NaDodSO4 linear-gradient polyacrylamide slab gel (31) pre-
pared with Sigma NaDodSO4. Note that the component
precipitated by anti-URF2-N antibodies formed a sharp band
at the expected position for component 11 in this gel system
(31). In electrophoretic runs of the total mitochondrial trans-
lation products in polyacrylamide gradient gels prepared with
NaDodSO4 from different sources (Sigma, MCB, and Bio-
Rad), it was found that the band corresponding to compo-
URF2-N URF4-C URF4L-C
+
pept pept pept pept pept pent
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FIG. 1. Fluorograms, after electrophoresis through a
NS URF2-N NaDodSO4/urea/polyacrylamide gel, of HeLa cell mito-
chondrial translation products precipitated by anti-URF2-
N or anti-URF4-C or anti-URF4L-C antibodies. Samples
of mitochondrial suspensions from cells labeled for 2 hr
with [355]methionine in the presence of emetine at 100
Ftg/ml (1.2-2 x 105 cpm; 75-380 ,ug of protein) were
precipitated with gamma globulins from the indicated
4 antisera, freed of anti-bovine serum albumin antibodies or
* from normal serum (250-500 ;Lg), and run through a
NaDodSO4/urea/polyacrylamide gel prepared with MCB
NaDodSO4 (A) or SigmaNaDodSO4 (B and C). Lanes: NS,
control experiment with gamma globulins from a normal
rabbit serum; COIl-N, immunoprecipitation experiment
with gamma globulins from an anti-COIl-N antiserum
freed of anti-bovine serum albumin antibodies; M, pattern
of mitochondrial translation products.
nents 9 and 11 (with component 11 representing a substantial
portion of it) had the same relative intensity and mobility with
respect to the adjacent bands; these observations suggested
that the mobility of component 11 was not affected,
as it was in NaDodSO4/urea/polyacrylamide gels, by the
source of NaDodSO4. The component precipitated by anti-
URF4-C antibodies yielded, besides a discrete band migrat-
ing at the expected position, heterogeneous material trailing
over the region of components 2 and 3.
Immunoprecipitation Experiments with Anti-URF5-N and
Anti-URF5-C Antibodies. Antibodies against the NH2-ter-
minal heptapeptide of the putative URF5 product, though
very reactive with the corresponding peptide conjugated to
ovalbumin, did not react significantly in the immunoprecip-
itation experiments with the [35S]methionine-labeled mito-
chondrial translation products. However, a very faint band
corresponding to component 1, which was apparently absent
in the normal serum control, was detectable over the back-
ground in the electrophoretic pattern (not shown).
The COOH-terminal hexapeptide of the putative URF5
product, which has a very hydrophobic character, was only
sparingly soluble and was difficult to couple to the carrier.
This peptide elicited only low-titer antibodies. These were
ineffective in precipitating any mitochondrial translation
product. Negative results with both the NH2 terminus- and
the COOH terminus-specific antibodies were obtained when
they were tested on a Triton X-100 mitochondrial lysate
under the conditions used for precipitation of intact com-
plexes (26, 30).
Fingerprinting Analysis of a Tryptic Digest of Component 1.
The very weak reaction given by the anti-URF5-N antibodies
with component 1 of the mitochondrial translation products
suggested that this component may be the URF5 product. In
agreement with this possibility was the fact that URFS is the
only reading frame large enough to code for a protein of the
size of component 1 [Mr 51,000, as estimated on the basis
-4a
Ub
26{
FIG. 2. Specific peptide inhibition of immunoprecipitation of
components 11, 4 and 5, and 26, respectively, by anti-URF2-N,
anti-URF4-C, and anti-URF4L-C antibodies. Samples ofa mitochon-
drial suspension (2 x 10- cpm; 130 ,tg of protein) from cells grown
for 22 hr in the presence ofchloramphenicol at 40 ,g/ml, then labeled
for 2 hr with [35S]methionine in methionine-free medium in the
presence of cycloheximide at 100 ,ug/ml, and finally chased for 2 hr
in complete medium were precipitated by anti-URF2-N, anti-URF4-
C, or anti-URF4L-C gamma globulins (125 ,g) in the absence (-) or
presence (+) of 5 ,ug of URF2-N, URF4-C, or URF4L-C peptide
(pept.), respectively. Lanes M show the pattern of mitochondrial
translation products.
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FIG. 3. Fluorogram after
electrophoresis through a
NaDodSO4/polyacrylamide
gradient gel (in Sigma NaDod-
SO4), of HeLa cell mitochon-
drial translation products pre-
cipitated by gamma globulins
from an anti-URF2-N, anti-
URF4-C, or anti-URF4L-C an-
tiserum. The samples were
equivalent to those electropho-
resed through a NaDodSO4/
urea/polyacrylamide gel in
Fig. 1A. Other lanes: NS, nor-
mal serum control; M, pattern
of mitochondrial translation
products.
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of its electrophoretic mobility (31); see below]. In order to
verify this tentative assignment, advantage was taken of the
fact that this product contains the sequence Lys-Met-Lys,
which would yield, upon trypsin digestion, a methionyllysine
dipeptide. Therefore, a bidimensional fingerprinting analysis
of component 1 after trypsin digestion was carried out.
Fig. 4 shows the fingerprinting pattern of a tryptic digest of
component 1, which was run together with a chemically
synthesized methionyllysine marker (22). Many spots of
different intensities are visible in the autoradiogram. One of
them corresponds perfectly in position and shape to the
methionyllysine marker. A much less intense spot, which has
migrated somewhat less toward the cathode, corresponds in
position to a minor portion of the marker representing deriva-
tives of the methionyllysine dipeptide in which the methionine
moiety is oxidized to the sulfoxide and sulfone level (as shown
by comparison with the migration of the completely oxidized
marker run at the border of the plate) (22). The methionyllysine
dipeptide is one of the most intense spots in the autoradiogram,
in spite of the fact that several tryptic digestion products
containing two to four methionine residues, and therefore more
highly labeled, would be expected. This is attributable to the
fact that the dipeptide is preferentially eluted from the gel during
the enzyme digestion.
DISCUSSION
Component 11 of the HeLa cell mitochondrial translation
products, the polypeptide specifically precipitated in this
work by anti-URF2-N antibodies, has been estimated previ-
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FIG. 4. Autoradiogram of a bidimensional fingerprint of the
products of trypsin digestion of component 1. [35S]Methionine-
labeled component 1 was isolated from a NaDodSO4 mitochondrial
lysate of HeLa cells by NaDodSO4/urea/polyacrylamide gel elec-
trophoresis and digested with trypsin as described (22). The lyophil-
ized digest was spotted in the lower half of a TLC plate (origin
marked 0ec) together with a sample of methionyllysine dipeptide
marker; another sample of the marker was spotted in the upper half
of the plate (origin marked °e). After electrophoresis, the plate was
dried, a sample of the marker and another sample of marker that had
been completely oxidized with 3% hydrogen peroxide to give 50%o
sulfoxide derivative and 50%o sulfone derivative (22) were spotted in
the left half of the plate [origins marked Oc and Oc (ox.), respec-
tively], and chromatography was run. The first dimension (electro-
phoresis) is in the horizontal direction (with the cathode on the right);
the second dimension (chromatography) is from bottom to top. The
dashed profiles indicate the positions of the native methionyllysine
dipeptide, as revealed by ninhydrin staining; the dotted profiles are
the positions of the oxidized dipeptide. In spot 2, the stained profile
extends beyond the right border of the radioactive profile, presum-
ably because of the presence of a stained peptide derived from
self-digestion of trypsin, which overlaps the oxidized peptide (22).
ously to have a Mr of =25,000 on the basis of its electropho-
retic mobility in a NaDodSO4/urea/polyacrylamide gel (31).
This molecular weight is smaller by =36% than that expected
for the protein encoded in URF2 (Mr 38,900; ref. 1). Similarly
the molecular weight estimates, based on electrophoretic
data, for components 4 and 5, which are specifically im-
munoprecipitated by anti-URF4-C antibodies (Mrs 39,000
and 36,000, respectively; ref. 31), are smaller by =24-30%
than the molecular weight predicted for the product of URF4
(Mr 51,400; ref. 1). Furthermore, the molecular weight
estimates for component 26, precipitated by anti-URF4L-C
antibodies (Mr 3,500), and component 1, identified as the
URF5N product (Mr, 51,000; ref. 31), are smaller by =z67%
and -23%, respectively, than the molecular weights expect-
ed for the proteins encoded in URF4L and URFS (Mrs 10,700
and 66,600, respectively; ref. 1). However, a similar bias in
size estimates based on electrophoretic mobility in NaDod-
S04/polyacrylamide gels has previously been observed for
other hydrophobic mitochondrial translation products (22,
23, 32, 33).
A plot of electrophoretic mobility vs. molecular weight
predicted from the DNA sequence for the mitochondrially
synthesized polypeptides so far identified (Fig. 5) clearly
shows that all these polypeptides, with the exception of
cytochrome c oxidase and the URFA6L product, have
relative mobilities in a NaDodSO4/urea/polyacrylamide gel
that are consistent with their expected molecular weights.
Therefore, the bias in size estimates based on electrophoretic
mobility in NaDodSO4/polyacrylamide gels of mtDNA-
encoded hydrophobic proteins appears to be due to the use
of proteins water-soluble in the absence of detergents for the
standard curve. In fact, the latter proteins are expected to
bind less NaDodSO4 than do hydrophobic proteins of equiv-
alent molecular weight and to migrate more slowly in an
electric field. Cytochrome c oxidase and the URF6L product
exhibit a lower-than-predicted mobility, presumably due to a
lower degree of NaDodSO4 binding. In fact, the URFA6L
product is unique among the human mitochondrially synthe-
sized polypeptides for having the amino acid composition of
a water-soluble protein (34); furthermore, the hydropathy
plot of human cytochrome c oxidase reveals that the COOH
terminus proximal half of the protein is only slightly hydro-
phobic (30).
The absolute specificity of the precipitation reactions
detected here and the observation that the polypeptides
precipitated by the specific antibodies have relative electro-
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FIG. 5. Plot of electrophoretic mobility of the human mitochon-
drial translation products in a NaDodSO4/urea/polyacrylamide gel
(in MCB NaDodSO4) versus molecular weight predicted from the
DNA sequence.
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phoretic mobilities perfectly consistent with the molecular
weights predicted from the DNA sequence for the products
of the corresponding reading frames strongly support the
conclusion that component 11, components 4 and 5, and
component 26 are encoded respectively in URF2, URF4, and
URF4L. In the case of component 1, which reacted only very
weakly with the anti-URF5-N antibodies, the tentative iden-
tification as the URF5 product, as also suggested by size
considerations, was corroborated by fingerprinting analysis
of a tryptic digest of this component-in particular by the
detection of the dipeptide methionyllysine in this digest. Of
the three amino acid sequences that would result in the
formation of the dipeptide methionyllysine after trypsin
digestion, the sequence Arg-Met-Lys and the NH2-terminal
Met-Lys sequence do not occur in any expected mitochon-
drial gene product; on the other hand, the sequence Lys-
Met-Lys is found in two other gene products besides the
URF5 product-i.e., in the polypeptides encoded by URF2
and URFA6L (1). However, the much smaller size of the
products of these two reading frames and the lack of
reactivity of anti-URF2-N (this work) and anti-URFA6L
antibodies (22) with component 1 clearly exclude URF2 and
URFA6L as the genes encoding component 1.
Components 4 and 5, which are partially resolved under
appropriate conditions of electrophoresis, were both precip-
itated by anti-URF4-C; therefore, presumably they are both
encoded by URF4. The nature of the change of the URF4
product, which results in two components with distinct
electrophoretic mobilities, is not known, nor has it been
investigated further.
The striking effect that the source of NaDodSO4 can have
on the electrophoretic mobility of some proteins has been
previously reported (35, 36). In fact, in a NaDodSO4 discon-
tinuous buffer system, both the separation ofthe proteins (35,
36) and their order of electrophoretic migration (35) are
influenced by the source of NaDodSO4. This phenomenon is
presumably related to the presence in the NaDodSO4 from
different sources of various amounts of contaminating alkyl
chains longer than C12, with higher affinities for certain
sequences. However, the presence of urea also can play a
role in the phenomenon (36; this work).
With the present identification ofthe polypeptides encoded
in URF2, URF4, URF4L, and URFS, seven of the eight
human URFs have been shown to be expressed in HeLa
cells. Of these seven URFs, URFA6L, because of its homol-
ogy to the yeast mtDNA gene (aapl) encoding subunit 8 of
the ATP synthase complex (10, 11) and of the results of
imtnunoprecipitation experiments (37), appears to code for a
component equivalent to ATPase 8. The other six URFs-
i.e., URF1, URF2, URF3, URF4, URF4L, and URFS-have
been shown recently to encode subunits of the respiratory
chain NADH dehydrogenase, and it has been proposed that
their designations be changed to ND [for NADH dehydrog-
enase (ND), ND2, ND3, ND4, ND4L, and ND5); ref. 26].
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